Top 16 MOMA Therapeutics investors
The most complete profiles first. Showing 16 of 16.
Christoph LengauerVerified
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Verified email available
Craig MuirVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Verified email available
Eli CasdinVerified
Venture Capital, Founder, Micro VC · United States
SeedHealth CareGeneticsWellnessWomen FoundedPortfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 76 more
Verified email available
Robert TepperVerified
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Verified email available
Noreen RizviVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Verified email available
Abbie Celniker
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 54 more
Contact details available
Cary Pfeffer
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
George Xu
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
Mark Levin
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceEducationPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
Neil Exter
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
Thomas Lips
Venture Capital, Private Equity Firm, Investor · Switzerland
SeedHealth CareWomen FoundedLife ScienceInformation Technology (IT)Portfolio: Black Diamond Therapeutics, Blueprint Medicines, TRACON Pharmaceuticals, Jounce Therapeutics and 30 more
Contact details available
Adeline Oursler
Micro VC · United States
Health CareGeneticsWellnessWomen FoundedPortfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more
Contact details available
Cody Tranbarger
Micro VC · United States
Health CareGeneticsWellnessWomen FoundedPortfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more
Contact details available
Kelly Moynihan
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
Walter Kowtoniuk
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
William Motley
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
Frequently asked questions
How many MOMA Therapeutics investors are on Angel Roster?
Angel Roster lists 16 MOMA Therapeutics investors. 5 of them (31%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (14), Private Equity Firms (7) and Micro VC Firms (3). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do MOMA Therapeutics investors invest in?
Among those that list a stage, the most common are Seed (10).
Where are MOMA Therapeutics investors based?
Most are based in the United States (15) and Switzerland (1).
Which companies have MOMA Therapeutics investors backed?
The most-backed portfolio companies among them are Revolution Medicines (16), Neon Therapeutics (16), Jounce Therapeutics (16), Tango Therapeutics (15) and Relay Therapeutics (15).
How do I contact MOMA Therapeutics investors?
Create a free Angel Roster account to search and filter all 16, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.